Form 8-K - Current report:
SEC Accession No. 0001193125-22-192331
Filing Date
2022-07-13
Accepted
2022-07-13 08:00:55
Documents
12
Period of Report
2022-07-12
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d219766d8k.htm   iXBRL 8-K 22916
  Complete submission text file 0001193125-22-192331.txt   139961

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA tcrt-20220712.xsd EX-101.SCH 2845
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE tcrt-20220712_lab.xml EX-101.LAB 17236
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tcrt-20220712_pre.xml EX-101.PRE 10805
6 EXTRACTED XBRL INSTANCE DOCUMENT d219766d8k_htm.xml XML 3229
Mailing Address 8030 EL RIO STREET HOUSTON TX 77054
Business Address 8030 EL RIO STREET HOUSTON TX 77054 (346) 355-4099
Alaunos Therapeutics, Inc. (Filer) CIK: 0001107421 (see all company filings)

EIN.: 841475642 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33038 | Film No.: 221080218
SIC: 2834 Pharmaceutical Preparations